See every side of every news story

Published 4 days ago • loading... • Updated 4 days ago

Teleflex Cuts Revenue Outlook as Biotronik Integration Slows

Summary by MyChesCo

WAYNE, PA — Teleflex Incorporated (NYSE: TFX) lowered its 2026 revenue outlook after integration of the acquired Biotronik Vascular Intervention business took longer than expected, even as second-quarter continuing-operations revenue …

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

1 Articles

Teleflex Cuts Revenue Outlook as Biotronik Integration Slows

WAYNE, PA — Teleflex Incorporated (NYSE: TFX) lowered its 2026 revenue outlook after integration of the acquired Biotronik Vascular Intervention business took longer than expected, even as second-quarter continuing-operations revenue …

4 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center0Last Updated4 days agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

MyChesCo broke the news 4 days ago on Sunday, August 16, 2026.

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics